Remyelination and multiple sclerosis: therapeutic approaches and challenges (Q38238466)

31 August 2017

title

Remyelination and multiple sclerosis: therapeutic approaches and challenges (English)

1 reference

31 August 2017

0 references

Meredith D Hartley

1

1 reference

31 August 2017

Ghadah Altowaijri

series ordinal

2

1 reference

31 August 2017

Dennis Bourdette

series ordinal

3

1 reference

31 August 2017

publication date

1 October 2014

1 reference

Current Neurology and Neuroscience Reports

31 August 2017

published in

1 reference

31 August 2017

volume

14

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

485

1 reference

Promoting remyelination in multiple sclerosis-recent advances

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Remyelination therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Neuroprotection and repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

21 January 2018

Dissecting demyelination

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Myelin regeneration: a recapitulation of development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Wrapping it up: the cell biology of myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Tapping into the glial reservoir: cells committed to remaining uncommitted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

The translational biology of remyelination: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Remyelination in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

In search of human oligodendroglia for myelin repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

A regenerative approach to the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Isolation and culture of rat and mouse oligodendrocyte precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Efficient induction of oligodendrocytes from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Myelin regeneration in multiple sclerosis: targeting endogenous stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Remyelination capacity of the MS brain decreases with disease chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Remyelination is extensive in a subset of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Myelination and support of axonal integrity by glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Central nervous system regeneration--where are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Progesterone synthesis in the nervous system: implications for myelination and myelin repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Sobetirome: a case history of bench-to-clinic drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Oligodendrocyte development and thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Testosterone treatment in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Retinoid X receptor gamma signaling accelerates CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Digestion products of the PH20 hyaluronidase inhibit remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0485-1

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.

21 January 2018

1 reference

12 December 2020

The Effect of Injections of Lysophosphatidyl Choline into White Matter of the Adult Mouse Spinal Cord

1 reference

12 December 2020

A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS.

1 reference

12 December 2020

Understanding CNS remyelination: clues from developmental and regeneration biology

1 reference

12 December 2020

The molecular orchestra of the migration of oligodendrocyte precursors during development

1 reference

12 December 2020

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis

1 reference

12 December 2020

Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice

1 reference

12 December 2020

10.1007/S11910-014-0485-1

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1049670442

0 references

1 reference